Back to top

aTyr Pharma (ATYR) Receives a Buy from Piper Sandler

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on aTyr Pharma, with a price target of $7.00. Rahimi covers t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

aTyr Pharma, Inc. (ATYR)